Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers discover hereditary protection a factor against depression

17.10.2006
Researchers from Umeå University, Sweden, in collaboration with Antwerp University, Belgium, have found a hereditary factor that is involved in the development of depression. Their study shows that a protein called TPH-2 plays a role in the development of both depression and manic depression.

The signal substance serotonin plays a significant role in brain functions. The level of serotonin in the brain has been shown to affect our emotions and moods.

The serotonin level in the brain is important in protecting against depression. Modern medicines for depression, so-called SSRI medicines (selective serotonin resorption inhibitors), work by raising the level of serotonin in the brain. The protein TPH-2 (brain-specific tryptophan hydroxylase), which is important for the regulation of the serotonin level in the brain, has long been suspected of playing a key role in the development of depression and manic depression.

The study, which was recently completed and is being published in the prestigious journal Archives of General Psychiatry, is based on an examination of what forms of TPH-2 (at the DNA level) are found in healthy individuals compared with the forms found in individuals with recurrent depression and manic depression, respectively.

The different forms of TPH-2 people inherit can result in differing levels of serotonin in the brain, thus providing varying degrees of protection against depression.

This comparison made it possible to show that the TPH-2 forms differed between healthy and affected individuals, which means that TPH-2 is involved in the development of these conditions. Certain forms were more common in healthy individuals, indicating that they have a protective effect against these conditions. There are as yet no clinical trials that have studied different THP-2 forms. All subjects who participated in the study live in northern Sweden.

The discovery of this hereditary protective factor, which is one of many, is a major piece of the puzzle in our understanding of the genesis and treatment of these disorders. Further research and economic resources are required for the discovery to lead to enhanced treatment and help for those affected.

The research has been carried out in a collaborative effort between a Swedish team of scientists under the direction of Professor Rolf Adolfsson and post-doctoral fellow Karl-Fredrik Norrback at the Research Unit of the Psychiatric Clinic in Umeå and the Department of Clinical Science, Section for Psychiatry, at Umeå University and a Belgian team of researchers from Antwerp University led by Professor Jurgen Del Favero and Ann van Den Boogaert, PhD. The study is being published in the prestigious journal Archives of General Psychiatry (Brain-specific tryptophan hydroxylase, TPH2, is associated with unipolar and bipolar disorder in a northern Swedish isolated population, 2006).

Depression is one of the most common disorders in the Western world, and according to the WHO (world Health Organization) it will be the most frequent disease by 2020. Three of ten Swedes experience depression some time during their lives, but it is still largely not known why. It is estimated that some 10 percent suffer from recurrent depression and an equally large group experience mood swings with varying degrees of manic depressive disease.

Despite the fact that these disorders cause a great deal of suffering, increased risk of suicide, and shortened lifetimes, as well as major socio-economic costs for society, the causes of these diseases are still largely a mystery. However, scientists agree that the conditions develop through a combination of heredity and environment, such as stress. Far too few research resources are still being allocated to scientists wishing to study mental health, even though the attitude toward research on mental health is improving.

Bertil Born | alfa
Further information:
http://www.umu.se

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>